Free tool
FAERS Monitor: Sterile Water In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017866 or its brand name (Sterile Water In Plastic Container, Sterile Water For Irrigation). Reports on generic versions are filed under their own applications.
Reports
5,062
Serious
2,859
56% of reports
Hospitalization
1,496
Death reported
180
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hereditary angioedema584
- fatigue273
- product dose omission issue265
- nausea254
- headache251
- weight increased242
- weight decreased239
- pain228
- inappropriate schedule of product administration217
- pyrexia210
- vomiting195
- dyspnoea188
- drug ineffective171
- off label use169
- diarrhoea158
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 11 |
| 2005 | 12 |
| 2006 | 3 |
| 2007 | 8 |
| 2008 | 7 |
| 2009 | 10 |
| 2010 | 19 |
| 2011 | 11 |
| 2012 | 18 |
| 2013 | 18 |
| 2014 | 112 |
| 2015 | 272 |
| 2016 | 222 |
| 2017 | 204 |
| 2018 | 583 |
| 2019 | 337 |
| 2020 | 209 |
| 2021 | 335 |
| 2022 | 546 |
| 2023 | 420 |
| 2024 | 614 |
| 2025 | 691 |
| 2026 | 400 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,097 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hereditary angioedemaSignal | 584 | 239.1 | 221.0 | 130,763 |
| inappropriate schedule of product administrationSignal | 217 | 5.0 | 4.4 | 697 |
| weight increasedSignal | 242 | 4.5 | 4.0 | 660 |
| product dose omission issueSignal | 265 | 3.7 | 3.3 | 538 |
| weight decreasedSignal | 239 | 3.6 | 3.1 | 443 |
| pyrexiaSignal | 210 | 2.5 | 2.2 | 195 |
| vomiting | 195 | 1.7 | 1.5 | 60 |
| headache | 251 | 1.7 | 1.5 | 68 |
| pain | 228 | 1.5 | 1.4 | 44 |
| fatigue | 273 | 1.5 | 1.3 | 40 |
| dyspnoea | 188 | 1.4 | 1.2 | 20 |
| nausea | 254 | 1.3 | 1.2 | 22 |
| diarrhoea | 158 | 1.0 | 0.9 | 0 |
| off label use | 169 | 0.8 | 0.7 | 8 |
| drug ineffective | 171 | 0.5 | 0.5 | 71 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.